Search Results 1131-1140 of 17144 for Birth Control Evolution
Participation eligibility · Age 18 years or older · Have membership at the Dan Abraham Healthy Living Center · Are new to DAHLC weight management program · Are ...
... contraception during dosing and for 5 days following end of treatment; History or presence of other concomitant liver diseases; Clinically significant hepatic ...
Vulnerable study population; Known atrial fibrillation; Implanted with a PPM or ICD; Pregnancy. Participating Mayo Clinic locations. Study statuses change often ...
Secondary Membranous Nephropathy (non-infectious etiology) will be used as controls. Exclusion Criteria: Secondary MN due to infectious causes. Inability or ...
... population. Mammography screening has been associated with a nearly 25% reduction in mortality, but Hispanic women have a lower incidence of mammography ...
A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with ...
About this study. Breast feeding is a challenge in patients who require long duration surgery. Nursing mothers as well as neurosurgical care team providers ...
Control patients will be those with thyroid nodules as well as autoimmune thyroid disease, with and without exposure to ICI. Participation eligibility.
Inability to effectively control myoelectrics for study purposes (control subjects only). Participating Mayo Clinic locations. Study statuses change often ...
Patient with child-bearing potential must discuss effective contraception with treating physician according to discuss potential risk on treatment strategy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.